RxSight grants new CEO Aziz Mottiwala stock options for 571,286 shares at $5.19 each

• RxSight granted new CEO Aziz Mottiwala inducement equity awards covering 2,883,424 shares, split between options and restricted stock units.
• Options cover 571,286 shares with a $5.19 exercise price; 25% vests after one year, then monthly vesting thereafter.
• RSUs cover 2,312,138 shares; 20% vests at year one, 20% at year two, 60% at year three.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RxSight Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607261600PRIMZONEFULLFEED9768079) on July 26, 2026, and is solely responsible for the information contained therein.